- Supported exchanges /
- PINK /
- EFTRW.PINK
eFFECTOR Therapeutics Inc (EFTRW PINK) stock market data APIs
eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. The company's lead product candidates comprise Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer; and Zotatifin, a small molecule inhibitor of eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors, as well as completed Phase 2a open-label expansion cohort in combination with fulvestrant and abemaciclib to treat patients with ER+ breast cancer. The company has a research collaboration and license agreement with Pfizer Inc. to research and develop small molecules that target eIF4E; and collaboration agreement with the Dana-Farber Cancer Institute on a Phase 2 clinical trial, evaluating Zotatifin as combination treatment in ER+ endometrial cancer and in low grade serous ovarian cancer. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.
eFFECTOR Therapeutics Inc Financial Data Overview
0.0006 | |
0.0006 | |
- | |
0.0006 | |
0.0006 | |
0.0003-0.1875 | |
0 | |
0 | |
675 K | |
0.4242 | |
0.8 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
eFFECTOR Therapeutics Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 675 K
- EBITDA -32 593 000
- Earnings Per Share -0.905
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get eFFECTOR Therapeutics Inc Earnings via APIs
- Latest Release 2021-09-30
- EPS/Forecast 0
Get eFFECTOR Therapeutics Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: